메뉴 건너뛰기




Volumn 104, Issue 1, 2013, Pages 65-70

Short-term neonatal outcome among term infants after in utero exposure to serotonin reuptake inhibitors

Author keywords

Clinical signs; Neonatal outcome; Serotonin reuptake inhibitors

Indexed keywords

SEROTONIN UPTAKE INHIBITOR; CITALOPRAM; FLUOXETINE; FLUVOXAMINE; PAROXETINE; SERTRALINE; VENLAFAXINE;

EID: 84878093221     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000350506     Document Type: Article
Times cited : (16)

References (17)
  • 1
    • 11144358525 scopus 로고    scopus 로고
    • Neonate characteristics after maternal use of antidepressants in late pregnancy
    • Kallen B: Neonate characteristics after maternal use of antidepressants in late pregnancy. Arch Pediatr Adolesc Med 2004; 158: 312-316.
    • (2004) Arch Pediatr Adolesc Med , vol.158 , pp. 312-316
    • Kallen, B.1
  • 2
    • 84865735200 scopus 로고    scopus 로고
    • Antidepressant use during pregnancy: The benefit-risk ratio
    • Koren G, Nordeng H: Antidepressant use during pregnancy: the benefit-risk ratio. Am J Obstet Gynecol 2012; 207: 157-163.
    • (2012) Am J Obstet Gynecol , vol.207 , pp. 157-163
    • Koren, G.1    Nordeng, H.2
  • 5
    • 33746869251 scopus 로고    scopus 로고
    • Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data
    • Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C: Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch Gen Psychiatry 2006; 63: 898-906.
    • (2006) Arch Gen Psychiatry , vol.63 , pp. 898-906
    • Oberlander, T.F.1    Warburton, W.2    Misri, S.3    Aghajanian, J.4    Hertzman, C.5
  • 6
    • 70349731700 scopus 로고    scopus 로고
    • Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes
    • Lund N, Pedersen LH, Henriksen TB: Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes. Arch Pediatr Adolesc Med 2009; 163: 949-954.
    • (2009) Arch Pediatr Adolesc Med , vol.163 , pp. 949-954
    • Lund, N.1    Pedersen, L.H.2    Henriksen, T.B.3
  • 7
    • 32244441984 scopus 로고    scopus 로고
    • Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants
    • Levinson-Castiel R, Merlob P, Linder N, Sirota L, Klinger G: Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Arch Pediatr Adolesc Med 2006; 160: 173-176.
    • (2006) Arch Pediatr Adolesc Med , vol.160 , pp. 173-176
    • Levinson-Castiel, R.1    Merlob, P.2    Linder, N.3    Sirota, L.4    Klinger, G.5
  • 8
    • 0842346538 scopus 로고    scopus 로고
    • Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior
    • Zeskind PS, Stephens LE: Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior. Pediatrics 2004; 113: 368-375.
    • (2004) Pediatrics , vol.113 , pp. 368-375
    • Zeskind, P.S.1    Stephens, L.E.2
  • 9
    • 18644382386 scopus 로고    scopus 로고
    • Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: Literature review and implications for clinical applications
    • Moses-Kolko EL, Bogen D, Perel J, Bregar A, Uhl K, Levin B, Wisner KL: Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA 2005; 293: 2372-2383.
    • (2005) JAMA , vol.293 , pp. 2372-2383
    • Moses-Kolko, E.L.1    Bogen, D.2    Perel, J.3    Bregar, A.4    Uhl, K.5    Levin, B.6    Wisner, K.L.7
  • 13
    • 33646684984 scopus 로고    scopus 로고
    • Selective serotonin-reuptake inhibitors and persistent pulmonary hypertension of the newborn
    • author reply 2188-2190
    • Reefhuis J, Rasmussen SA, Friedman JM: Selective serotonin-reuptake inhibitors and persistent pulmonary hypertension of the newborn. N Engl J Med 2006; 354: 2188-2190, author reply 2188-2190.
    • (2006) N Engl J Med , vol.354 , pp. 2188-2190
    • Reefhuis, J.1    Rasmussen, S.A.2    Friedman, J.M.3
  • 14
    • 34347262073 scopus 로고    scopus 로고
    • For the Osteoporotic Fractures in Men Study Group: Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men
    • Haney EM, Chan BK, Diem SJ, Ensrud KE, Cauley JA, Barrett-Connor E, Orwoll E, Bliziotes MM; for the Osteoporotic Fractures in Men Study Group: Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. Arch Intern Med 2007; 167: 1246-1251.
    • (2007) Arch Intern Med , vol.167 , pp. 1246-1251
    • Haney, E.M.1    Chan, B.K.2    Diem, S.J.3    Ensrud, K.E.4    Cauley, J.A.5    Barrett-Connor, E.6    Orwoll, E.7    Bliziotes, M.M.8
  • 15
    • 84857121124 scopus 로고    scopus 로고
    • Maternal use of selective serotonin reuptake inhibitors during pregnancy and neonatal bone density
    • Dubnov-Raz G, Hemila H, Vurembrand Y, Kuint J, Maayan-Metzger A: Maternal use of selective serotonin reuptake inhibitors during pregnancy and neonatal bone density. Early Hum Dev 2012; 88: 191-194.
    • (2012) Early Hum Dev , vol.88 , pp. 191-194
    • Dubnov-Raz, G.1    Hemila, H.2    Vurembrand, Y.3    Kuint, J.4    Maayan-Metzger, A.5
  • 16
    • 84861193049 scopus 로고    scopus 로고
    • Prenatal SSRI exposure alters neonatal corticosteroid binding globulin, infant cortisol levels, and emerging HPA function
    • Pawluski JL, Brain UM, Underhill CM, Hammond GL, Oberlander TF: Prenatal SSRI exposure alters neonatal corticosteroid binding globulin, infant cortisol levels, and emerging HPA function. Psychoneuroendocrinology 2012; 37: 1019-1028.
    • (2012) Psychoneuroendocrinology , vol.37 , pp. 1019-1028
    • Pawluski, J.L.1    Brain, U.M.2    Underhill, C.M.3    Hammond, G.L.4    Oberlander, T.F.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.